2025-11-14T09:22:44-06:00 2024-12-31 390747409 REILLY PENNER & BENTON LLP 1233 NORTH MAYFAIR RD SUITE 302 MILWAUKEE WI 532263255 990 2024-01-01 272314549 BEAT CHILDHOOD CANCER FOUNDATION INC BEAT 4143784420 P O BOX 850804 BRAINTREE MA 02185 SARAH BARTOSZ EXECUTIVE DIRECTOR 4143784420 2025-11-10 1 1 BRANDON PANKA P01596345 4142717800 2024 2025-03-06 01:10:19Z SARAH BARTOSZ P O BOX 850804 BRAINTREE MA 02185 2064096 0 X BEATCC.ORG X 2010 MA BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. OUR VISION IS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS. 3 2 3 50 0 0 1057317 1446223 0 0 202 3331 177502 171322 1235021 1620876 1339000 1527266 0 0 341526 370890 0 0 48806 173857 239233 1854383 2137389 -619362 -516513 3646942 2797533 857834 524938 2789108 2272595 X BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. OUR VISION IS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS. 0 0 1931678 1527266 2462 BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. THE ORGANIZATION AIMS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS. THE PRIMARY PURPOSE AND ACTIVITY OF BEAT CHILDHOOD CANCER IS TO RAISE FUNDS TO FACILITATE RESEARCH GRANTS TO BEAT CHILDHOOD CANCER RESEARCH CONSORTIUM.BEAT CHILDHOOD CANCER DRIVES PATIENT-AFFECTING CHILDHOOD CANCER CLINICAL TRIALS, EXPANDING HOW RESEARCH IS DONE. PRECISION MEDICINE IS THE FUTURE OF CANCER TREATMENT. WE ARE HELPING KIDS NOW WITH TARGETED THERAPIES AND ORAL DRUGS WITH LOW SIDE EFFECTS AIMED AT PREVENTING OR TREATING RELAPSE WITHOUT PUNITIVE, LONG-TERM SIDE EFFECTS. OUR COMMUNITY OF CLINICIANS, SCIENTISTS, PARENTS, AND SUPPORTERS HAVE BUILT AN INTERNATIONAL INFRASTRUCTURE AND TEAM OF RESEARCH AND CLINICAL COLLABORATORS TO ENSURE KIDS HAVE ACCESS TO THESE THERAPIES.SINCE 2010, OUR GROUP HAS OPENED NINETEEN CLINICAL TRIALS, DIRECTLY AFFECTING MORE THAN 1,000 KIDS. WHERE THE TRADITIONAL CLINICAL TRIAL MODEL OFTEN TAKES SEVERAL YEARS TO START ENROLLING PATIENTS, THE BEAT CHILDHOOD CANCER RESEARCH CONSORTIUM AIMS TO ENROLL CHILDREN ONCLINICAL TRIALS WITHIN ONE YEAR. OUR PATIENT-CENTERED FOCUS IS NOT BASED ON A SINGLE DOCTOR, HOSPITAL, OR DRUG. IT IS ABOUT HELPING EVERY CHILD, EVERYWHERE SURVIVE AND THRIVE FOLLOWING A CHILDHOOD CANCER DIAGNOSIS. 1931678 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 3 0 1 3 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 3 2 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 1 1 1 1 0 MA X X SARAH BARTOSZ 4143784420 PO BOX 850804 BRAINTREE MA 02185 PATRICK LACEY PRESIDENT 20.00 X X 0 0 34054 ERIC CAISSE DIRECTOR 1.00 X 0 0 0 MARK TAYLOR DIRECTOR 1.00 X 0 0 0 SARAH BARTOSZ EXECUTIVE DIRECTOR 40.00 X 142793 0 13723 142793 0 47777 1 0 1 0 CI DESIGN 306 N MILWAUKEE ST MILWAUKEE WI 53202 VIDEOGRAPHY AND MESSAGING FORWARD 103763 1 153533 1292690 35014 1446223 127 127 199643 196439 3204 3204 3204 415768 153533 246781 168987 168987 OTHER INCOME 900099 2335 2335 2335 1620876 2462 0 172191 1527266 1527266 210220 159767 50453 131140 99666 31474 9004 6495 2243 266 20526 15600 4926 14250 6062 6424 1764 111168 47290 50114 13764 5720 2860 2860 30275 15885 3530 10860 25394 11930 4911 8553 17360 8680 8680 3103 1551 1552 2147 2147 2203 1013 683 507 PROGRAM ACTIVITIES 27613 27613 2137389 1931678 156905 48806 1374184 1214276 196483 0 2072437 1564566 17000 10735 9044 3838 1691 3646942 2797533 18834 24938 839000 500000 857834 524938 X 373803 380327 2415305 1892268 2789108 2272595 3646942 2797533 -516513 0 X 0 1 X 1 0 X 2162103 1741917 4682993 1057317 1446223 11090553 2162103 1741917 4682993 1057317 1446223 11090553 830815 10259738 202 3331 3533 389185 418103 807288 11901374 0.86210 0.91810 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10735 9044 1691 1691 X 1698702 0 1698702 -77826 -77826 1620876 2215217 77828 77828 2137389 0 2137389 PART X, LINE 2: THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE. THE FOUNDATION IS NOT CONSIDERED A PRIVATE FOUNDATION BY THE INTERNAL REVENUE SERVICE. THE FOUNDATION DOES NOT CONSIDER ANY OF ITS SUPPORT AND REVENUES TO BE UNRELATED BUSINESS INCOME AND, ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN PROVIDED IN THE ACCOMPANYING FINANCIAL STATEMENTS. THE FOUNDATION HAS IMPLEMENTED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH U.S. GAAP. THIS STANDARD DESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN AND ALSO PROVIDES GUIDANCE ON VARIOUS RELATED MATTERS SUCH AS RECOGNIZING INTEREST, PENALTIES AND DISCLOSURES REQUIRED. MANAGEMENT OF THE FOUNDATION EVALUATES THE UNCERTAIN TAX POSITIONS TAKEN, IF ANY, AND CONSULTS WITH OUTSIDE COUNSEL AS DEEMED NECESSARY. THE FOUNDATION RECOGNIZES INTEREST AND PENALTIES, IF ANY, RELATED TO UNRECOGNIZED TAX LIABILITIES IN INCOME TAX EXPENSE. IN MANAGEMENT'S OPINION, THE FOUNDATION HAS NOT TAKEN ANY UNCERTAIN TAX POSITIONS AND, ACCORDINGLY, HAS NOT REPORTED A CORRESPONDING LIABILITY IN THE FOUNDATION'S FINANCIAL STATEMENTS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES -77,826. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES 77,826. ROUNDING 2. GOLD GALA 500209 147342 352867 52199 12330 68194 9500 22715 FISHING 69092 6191 62901 995 4320 40419 4 14232 7780 14097 569301 153533 415768 53194 12330 86746 17280 77231 246781 168987 1 PENNSYLVANIA STATE UNIVERSITY PO BOX 850 HERSEY PA 17033 246000376 115 1527266 0 FUNDING FOR CLINICAL TRIALS 1 PART I, LINE 2: BEAT CHILDHOOD CANCER MANAGEMENT AND DIRECTORS ARE IN FREQUENT COMMUNICATION WITH THE BCC RESEARCH CONSORTIUM AND PARTICIPATE IN STATUS CALLS AND MEETINGS WHERE THE PROGRESS AND RESULTS OF CLINICAL TRIALS ARE DISCUSSED. 0 0 0 0 0 0 0 0 0 SARAH BARTOSZ EXECUTIVE DIRECTOR 142793 0 0 0 0 0 0 0 13723 0 156516 0 0 0 X GALA EVENT ITEMS 10 32814 COMPARABLE SALES X FISHING EVENT ITEMS 2 2200 COMPARABLE SALES 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS REVIEWS AND APPROVES ALL EMPLOYEE SALARIES. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE AVAILABLE UPON REQUEST.